ThreeD Capital Inc. Completes Private Placement Financing
Each Unit issued as part of the Private Placement is comprised of one common share and one common share purchase warrant (a 'Warrant'). Each whole Warrant entitles the holder thereof to acquire one common share of the Company at an exercise price of $0.15 per common share for a period of 60 months. No commission or finders' fees were paid as part of the Private Placement.
All securities issued and issuable in connection with the Private Placement will be subject to a four-month and a day hold period expiring on December 2, 2025.
In connection with the Private Placement, management and directors of the Company (collectively the 'Insiders'), purchased a total of 11,600,000 Units. Insiders' participation in the Private Placement constitutes a 'related party transaction' pursuant to Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions ('MI 61-101'). The Company is relying on the exemption from the valuation and minority shareholder approval requirements under MI 61-101, as the fair market value of the Insiders' participation in the Private Placement does not exceed 25% of the market capitalization of the Company.
About ThreeD Capital Inc.
ThreeD is a publicly-traded Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors. ThreeD's investment strategy is to invest in multiple private and public companies across a variety of sectors globally. ThreeD seeks to invest in early stage, promising companies where it may be the lead investor and can additionally provide investees with advisory services and access to the Company's ecosystem.
For further information:
Matthew Davis, CPA
Chief Financial Officer and Corporate Secretary
info@threedcap.com
Phone: 416-941-8900
The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.
Forward-Looking Statements
This news release contains certain forward-looking statements and forward-looking information (collectively referred to herein as 'forward-looking statements') within the meaning of Canadian securities laws including, without limitation, statements with respect to the future investments by the Company. All statements other than statements of historical fact are forward-looking statements. Undue reliance should not be placed on forward-looking statements, which are inherently uncertain, are based on estimates and assumptions, and are subject to known and unknown risks and uncertainties (both general and specific) that contribute to the possibility that the future events or circumstances contemplated by the forward-looking statements will not occur. Although the Company believes that the expectations reflected in the forward looking statements contained in this press release, and the assumptions on which such forward-looking statements are made, are reasonable, there can be no assurance that such expectations will prove to be correct. Readers are cautioned not to place undue reliance on forward-looking statements included in this document, as there can be no assurance that the plans, intentions or expectations upon which the forward-looking statements are based will occur. By their nature, forward-looking statements involve numerous assumptions, known and unknown risks and uncertainties that contribute to the possibility that the predictions, forecasts, projections and other forward-looking statements will not occur, which may cause the Company's actual performance and results in future periods to differ materially from any estimates or projections of future performance or results expressed or implied by such forward-looking statements. The forward-looking statements contained in this news release are made as of the date hereof and the Company does not undertake any obligation to update publicly or to revise any of the included forward-looking statements, except as required by applicable law. The forward-looking statements contained herein are expressly qualified by this cautionary statement.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
an hour ago
- Business Insider
Palantir exec calls LLMs a 'jagged intelligence' and outlines the company's next steps in the AI race
A Palantir exec had some strong words for Large Language Models. The Denver-based AI software company reported its first-ever billion-dollar quarter in Monday's Q2 earnings report, and the executives opened the investors call with comments on LLMs and how it plans to win the AI race. " LLMs, on their own, are at best a jagged intelligence divorced from even basic understanding," Ryan Taylor, the company's chief revenue officer and chief legal officer, told shareholders on the earnings call. "In one moment, they may appear to outperform humans in some problem-solving task, but in the next, they make catastrophic errors no human would ever make." "By contrast, our ontology is pure understanding concretized in software. This is reality, not rhetoric," Taylor added, referring to a company approach to AI that is based on using logic and data to recreate a digital model of how an organization works. These comments came after the company smashed analyst expectations and nearly doubled its commercial revenue in the US since last year's second quarter to $628 million, mostly thanks to a 10-year, $10 billion consolidated contract with the US Army. Company executives also outlined how it plans to win the AI race and what kind of talent would thrive at Palantir. Shyam Sankar, chief technology officer, told investors that the Trump administration's new AI Action Plan, which promotes the deregulation of AI, has taken "all the brakes off" and that industry customers are "really excited to get to work." These comments are in response to a Bank of America analyst, who asked how Palantir plans to win the AI race both in innovation and in talent retention. "If you are a highly talented person and would believe that the West is superior or at least tolerant of me telling you it every day, you'll not find a place anywhere I've seen — and now over 20 years I've interacted with almost every agency in the West, many of the largest companies, many of the smaller companies — that is comparable on time of joining to full agency like Palantir," Karp said toward the end of the call. "If you come to Palantir, your career is set," he added.
Los Angeles Times
2 hours ago
- Los Angeles Times
Trump's praise for Sweeney ad sends American Eagle stock surging
American Eagle Outfitters saw its stock price surge more than 20% on Monday, after President Trump praised the retailer's controversial marketing campaign featuring actress Sydney Sweeney on his Truth Social platform. 'Sydney Sweeney, a registered Republican, has the 'HOTTEST' ad out there. It's for American Eagle, and the jeans are 'flying off the shelves.' Go get 'em Sydney!' Trump wrote Monday morning, sparking the rally in shares that began after markets opened. The president's endorsement comes amid a firestorm of criticism over the campaign. The controversy centers on a promotional video featuring Sweeney that was posted to American Eagle's social media channels. The video has since been removed. In the teaser, the 'Euphoria' actress discusses hereditary traits in a sultry voice, stating: 'Genes are passed down from parents to offspring, often determining traits like hair color, personality and even eye color. My jeans are blue.' As she speaks, the video shows Sweeney zipping up her jeans before the camera pans up her body and focuses on her face and blue eyes, framed by blonde hair. The visual emphasis on Sweeney's features prompted backlash from critics on the internet who were quick to accuse the ad of promoting eugenics and aligning with white nationalist messaging. Pittsburgh-based American Eagle defended the campaign in a statement it posted to Instagram last Friday, saying it 'is and always was about the jeans.' Trump used the opportunity to criticize what he called 'woke' advertising, citing examples like Jaguar's recent rebrand and Bud Light's partnership with transgender influencer Dylan Mulvaney in 2023. 'The market cap destruction has been unprecedented, with BILLIONS OF DOLLARS SO FOOLISHLY LOST,' he wrote, contrasting those campaigns with American Eagle's approach. The stock surge represents the latest chapter in what has become a meme-driven rally for American Eagle, which initially jumped last month when retail traders piled into the stock following the campaign's debut. American Eagle has faced significant financial challenges in recent months. In May, the retailer withdrew its full-year guidance and announced a $75-million write-off of spring and summer merchandise due to slow sales, steep discounting and difficult market conditions. The company reported a first-quarter net revenue of $1.1 billion, down 5% from the prior year, with comparable sales falling 3%. Several prominent Republicans, including Vice President JD Vance and Sen. Ted Cruz, have also defended Sweeney and the campaign against criticism. The actress herself has not publicly addressed the controversy surrounding the advertisements. American Eagle shares closed at $13.28 on Monday, up 24%.
Business Upturn
2 hours ago
- Business Upturn
iSpecimen Inc. Announces Closing of Approximately $1.75 Million Private Placement Priced At-the-Market
By GlobeNewswire Published on August 5, 2025, 03:45 IST WOBURN, Mass., Aug. 04, 2025 (GLOBE NEWSWIRE) — iSpecimen Inc. (Nasdaq: ISPC) ('iSpecimen' or the 'Company'), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it closed its previously announced private placement pursuant to a securities purchase agreement with accredited investors for aggregate gross proceeds of approximately $1.75 million, before deducting fees to the placement agent and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering to pay $500,000 for marketing and advertising services to be provided by IR Agency LLC, and the remainder for working capital and general corporate purposes. In connection with the offering, the Company issued 1,559,828 shares of common stock (or pre-funded warrants to purchase shares of common stock) at a purchase price of $1.122 per share, priced at-the-market under Nasdaq rules. The offering closed on August 4, 2025. WestPark Capital, Inc. acted as the exclusive placement agent in connection with the offering. Additional details regarding the offering will be available in a Form 8-K to be filed by the Company with the Securities and Exchange Commission (the 'SEC'). The securities described above have not been registered under the Securities Act of 1933, as amended, and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors. Pursuant to a registration rights agreement with the investor, the Company has agreed to file one or more registration statements with the SEC covering the resale of the shares of common stock and the shares issuable upon exercise of the pre-funded warrants. This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. About iSpecimen iSpecimen (Nasdaq: ISPC) offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. For more information, please visit . Safe Harbor Statement Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute 'forward-looking statements.' These statements include, but are not limited to, statements concerning the development of our company. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The reader is cautioned not to rely on such forward-looking statements. Such forward-looking statements relate to future events or our future performance. In evaluating these forward-looking statements, you should consider various factors, including the uncertainty regarding future commercial success; risks and uncertainties associated with market conditions and the Company's ability to satisfy the closing conditions related to the Offering. These and other factors may cause our actual results to differ materially from any forward-looking statements. Forward-looking statements are only predictions and actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including factors discussed in the 'Risk Factors' section of the Company's Annual Report on Form 10-K for the year ended December 31, 2024, filed with the SEC on April 14, 2025, as well as other SEC filings. Any forward-looking statements contained in this press release speak only as of the date hereof and, except as required by federal securities laws, iSpecimen specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise. [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
